Capsensixx AG (FRA:CPX) EBITDA Margin %: 6.25% (As of Dec. 2025) — 14% Below Median


FRA:CPX Capsensixx AG FRA:CPX
87 GF Score
Price €21.40
GF Value €27.46
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Capsensixx AG EBITDA Margin %?

Capsensixx AG FRA:CPX 87 EBITDA Margin % is 6.25% as of Dec. 2025, which is 14% below its 10-year median of 7.28. GuruFocus rates FRA:CPX with a GF Score™ of 87/100 and a GF Value™ of €27.46 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 665 Asset Management companies, Capsensixx AG ranks worse than 70.83% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Capsensixx AG's EBITDA for the six months ended in Dec. 2025 was €7.4 Mil. Capsensixx AG's Revenue for the six months ended in Dec. 2025 was €118.1 Mil. Therefore, Capsensixx AG's EBITDA margin for the quarter that ended in Dec. 2025 was 6.25%.


Capsensixx AG  (FRA:CPX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Capsensixx AG EBITDA Margin % Related Terms


Capsensixx AG EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Capsensixx AG's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capsensixx AG EBITDA Margin % Chart

Capsensixx AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.68 8.55 7.52 6.48 6.30

Capsensixx AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.13 7.15 5.92 6.37 6.25

FRA:CPX vs BLK, BX, KKR: EBITDA Margin % Comparison

For the Asset Management subindustry, Capsensixx AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Capsensixx AG EBITDA Margin % vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Capsensixx AG's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Capsensixx AG's EBITDA Margin % falls into.


FRA:CPX
87GF Score
Capsensixx AG FRA:CPX
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Capsensixx AG EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Capsensixx AG's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=12.649/200.721
=6.30 %

Capsensixx AG's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=7.381/118.078
=6.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 6.25% mean?
Capsensixx AG (FRA:CPX) has a EBITDA Margin % of 6.25% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Capsensixx AG and its competitors. This is 14% below median its historical median of 7.28. Over the past decade, Capsensixx AG's EBITDA Margin % has ranged from 5.68 to 10.82. According to the industry distribution chart, Capsensixx AG ranks #471 out of 665 companies in the Asset Management industry, placing it in the top 70.8%.
Is Capsensixx AG's EBITDA Margin % too high?
Capsensixx AG's current EBITDA Margin % of 6.25% is 14% below median its 10-year median of 7.28. Over the past 10 years, this metric has ranged from a low of 5.68 to a high of 10.82. The Asset Management industry median EBITDA Margin % is 30.29. Capsensixx AG's value of 6.25% is 79.4% below this industry median. Based on the distribution chart, Capsensixx AG ranks #471 out of 665 companies in the Asset Management industry, which is below the industry midpoint. Overall, Capsensixx AG has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Capsensixx AG's EBITDA Margin % compare to BLK and BX?
According to the Asset Management industry distribution chart, Capsensixx AG ranks #471 out of 665 companies for EBITDA Margin %. This places Capsensixx AG in the lower half of its industry. The industry median EBITDA Margin % is 30.29. Capsensixx AG's value of 6.25% is 79.4% below this benchmark. Historically, Capsensixx AG's own EBITDA Margin % has ranged from 5.68 to 10.82 over the past decade. While the company's 10-year median is 7.28 vs. the industry median of 30.29, Capsensixx AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Asset Management company?
The median EBITDA Margin % among Asset Management companies is 30.29, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Capsensixx AG's current EBITDA Margin % of 6.25% is 79.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Capsensixx AG and its competitors. For the Asset Management industry, the median EBITDA Margin % is 30.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Capsensixx AG's current EBITDA Margin % is 6.25%, which is 14% below median its own 10-year median of 7.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capsensixx AG stock overvalued right now?
Based on GuruFocus' analysis, Capsensixx AG (FRA:CPX) is currently considered Modestly Undervalued. The stock's GF Value™ is €27.46, compared to a current price of €21.40 — trading 22.1% below its estimated fair value. The current EBITDA Margin % is 6.25%, which is 14% below median its 10-year median of 7.28 and 79.4% below the Asset Management industry median of 30.29. Capsensixx AG's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Capsensixx AG (FRA:CPX), the current EBITDA Margin % is 6.25% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Capsensixx AG (FRA:CPX) Overvalued in 2026?

Based on GuruFocus' analysis, Capsensixx AG stock appears to be undervalued. The current stock price of €21.40 is trading 22.1% below its estimated GF Value™ of €27.46. GuruFocus considers Capsensixx AG to be Modestly Undervalued.

Key valuation signals for FRA:CPX:

  • EBITDA Margin %: 6.25% (14% below median its 10-year median of 7.28)
  • GF Value™: €27.46 vs. price of €21.40 (22.1% below fair value)
  • GF Score™: 87/100 with 5 warning signs
  • Industry Position: 79.4% below the Asset Management median (#471 of 665)

No single metric tells the full story. See the FRA:CPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Capsensixx AG Business Description

Other Exchanges CPX:Germany
Address Bettinastrasse 57-59, Frankfurt, DEU, D-60325
Capsensixx AG is a provider of financial administration as a service. The company is divided into two segments namely Funds management, Administration and Accounting Segment which includes fund management and fund accounting; and Securitisations which provides Advisory services in the field of financial engineering, securitisation and provision of director and administrative services to corporate clients in Luxembourg.
87GF Score

Get the complete analysis for FRA:CPX

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40
Price
€27.46
GF Value